As a consequence, the clinical implications such as the correlation with mutational receptors status, clinical outcome, prognosis, therapeutic responsiveness or the exact GIST population with IGF1R deregulation require further investigation. This evidence concerns the gene IGF1R and gastrointestinal stromal tumor.